Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.18% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PUT
Johnson & Johnson
JNJ
$614B
| $475M | 0.1% |
3,066,400
+344,000
| +13% | +$55.5M |
|
102
PUT
Qualcomm
QCOM
$171B
| $475M | 0.1% |
3,723,300
-519,400
| -12% | -$64.6M |
|
103
DexCom
DXCM
$32.8B
| $469M | 0.1% |
4,038,374
+1,805,530
| +81% | +$202M |
|
|
104
CALL
Qualcomm
QCOM
$171B
| $469M | 0.1% |
3,673,400
-685,000
| -16% | -$85.2M |
|
105
FedEx
FDX
$74.1B
| $467M | 0.1% |
2,045,119
+1,753,457
| +601% | +$356M |
|
106
PUT
Intel
INTC
$509B
| $467M | 0.1% |
14,300,200
+3,861,500
| +37% | +$109M |
|
107
Walmart Inc
WMT
$888B
| $464M | 0.1% |
9,436,113
+7,247,277
| +331% | +$344M |
|
108
ResMed
RMD
$32.4B
| $460M | 0.1% |
2,102,073
+942,177
| +81% | +$204M |
|
109
Becton Dickinson
BDX
$46.9B
| $460M | 0.1% |
1,859,103
+43,589
| +2% | +$10.7M |
|
110
McDonald's
MCD
$191B
| $458M | 0.1% |
1,638,248
+1,467,612
| +860% | +$393M |
|
111
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.74B
| $457M | 0.1% |
10,425,100
+7,596,000
| +268% | +$431M |
|
112
PUT
Citigroup
C
$230B
| $452M | 0.1% |
9,647,600
-1,418,000
| -13% | -$69.6M |
|
113
Align Technology
ALGN
$12.4B
| $451M | 0.1% |
1,350,186
+947,673
| +235% | +$280M |
|
114
PUT
ASML
ASML
$658B
| $441M | 0.1% |
648,400
-57,800
| -8% | -$37.1M |
|
|
XYZ
115
CALL
Block Inc
XYZ
$50.4B
| $440M | 0.1% |
6,411,000
-407,200
| -6% | -$30.5M |
|
|
HZNP
116
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $434M | 0.1% |
3,978,009
+2,712,069
| +214% | +$300M |
|
117
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
| $432M | 0.1% |
1,299,300
-991,200
| -43% | -$329M |
|
118
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
| $426M | 0.09% |
13,265,400
+5,948,500
| +81% | +$207M |
|
119
PUT
Micron Technology
MU
$1.01T
| $418M | 0.09% |
6,933,600
+126,900
| +2% | +$7.44M |
|
120
Revvity
RVTY
$12.4B
| $417M | 0.09% |
3,130,076
+1,850,058
| +145% | +$244M |
|
121
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $416M | 0.09% |
10,539,200
-13,163,100
| -56% | -$523M |
|
122
Aptiv
APTV
$10.1B
| $414M | 0.09% |
3,689,577
+666,689
| +22% | +$73.6M |
|
123
CALL
IBM
IBM
$222B
| $411M | 0.09% |
3,136,600
-1,352,800
| -30% | -$181M |
|
|
124
PUT
FedEx
FDX
$74.1B
| $408M | 0.09% |
1,784,900
-453,800
| -20% | -$92.1M |
|
125
PUT
UnitedHealth
UNH
$370B
| $407M | 0.09% |
861,800
-479,400
| -36% | -$231M |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,688 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,468 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.